STUB · StubHub Holdings, Inc.

Current Thesis

Busted-IPO turnaround in mid-recovery. STUB priced at $23.50 in its September 2025 NYSE IPO, de-rated to a $5.74 low, and has now more than doubled off that bottom on a Q1 2026 profitability inflection first GAAP profit, free cash flow up roughly 90% YoY, and active deleveraging. The catalyst that mattered (the May 13 print) is a month old; the stock has since pushed back above the $8.50–11 sell-side price-target cluster and pressed $11.47 on June 12. The recovery is genuine, but at ~$11.46 the market is already paying through near-term analyst marks with no fresh binary until the estimated ~Aug 3 Q2 report. This is a turnaround that has done its easy work, now trading on momentum and a seasonal summer-events tailwind rather than a new catalyst.

Bull Case

• Q1 2026 (reported 2026-05-13): revenue $446.0M (+12% YoY), GMS $2.2B (+7% YoY), net income $48.0M versus a prior-year loss, Adjusted EBITDA $72.1M (+50% YoY, 16% margin). The return-to-profit drove a ~+14% single-session pop.
• Cash generation inflected hard: operating cash flow $298.4M and FCF $290.6M, both up ~90% YoY; $1.5B cash on hand; an additional $100M of debt retired in May 2026, taking net leverage to 4.0x. The deleveraging story is tracking, not promised.
• FY2026 guide reiterated on the print: GMS $9.9–10.1B, Adjusted EBITDA $400–420M. Q2 is seasonally the strongest ticketing quarter (NBA Finals June, summer concert tours), which feeds the next GMS line.
• Sell-side targets are ratcheting up, not down: Guggenheim $7.50→$8.50, JPMorgan $10→$11, Morgan Stanley $8.75→$10 (2026-06-10). Consensus across ~14 analysts sits around $13.38, a "Buy."
• Speculative flow leaning in: a Jul 17 $12.5 call sweep printed near the ask on 2026-06-09 (ref $10.38), and June 12 traded +7.91% on ~9.4M shares re-engagement well above the post-Q1 base.

Bear Case

• Still ~51% below the $23.50 IPO; the dominant near-term sell-side stance is Hold/Equal-Weight, and at $11.46 the stock already sits at or above the low-to-mid target band ($8.50–11). The upside that remains lives in dispersed high targets, not the cluster.
• 7% GMS growth is a deceleration from the IPO-era growth pitch. Secondary ticketing is a low-moat, price-competitive market Vivid Seats (SEAT), SeatGeek, and Ticketmaster/Live Nation (LYV) all contest the same inventory and take-rate.
• 4.0x net leverage is still elevated; the equity case leans on continued debt paydown rather than top-line reacceleration, which caps the re-rating multiple.
• No confirmed catalyst until the estimated ~Aug 3 Q2 print. A month-old earnings pop with price extended above analyst marks is a low-information stretch where momentum can reverse on no news.
• Recent IPO, thin float, violent realized volatility (52-week range $5.74–27.89). Moves overshoot in both directions.
• The registry's "prediction-markets-sports-betting" tag is a mislabel STUB is live-events ticket resale, not a sportsbook or prediction-market operator. A thesis leaning on that adjacency is mispriced from the start.

Setup & Price Structure

• Last ~$11.46 (2026-06-12), +7.91% on the session, ~9.4M shares; intraday range $10.43–11.47; prior close $10.62. Market cap ~$4.30B.
• 52-week range $5.74–27.89. Price has recovered from the $5.74 capitulation low, based around $9–10 after the May print, and broke above $11 on June 12 volume.
• The $11–12.5 band is the live battleground the call sweep is positioned at the $12.5 strike, and a hold above it would clear the post-IPO supply that has capped prior bounces.
• Because price now trades above the $8.50–11 target cluster, the next leg requires the tape to underwrite the turnaround beyond what sell-side currently models. That is an extended stance relative to near-term fundamentals, not a fresh breakout off support.

Catalyst Calendar (next 30 days)

• No confirmed binary event inside 30 days as of 2026-06-14.
• Q2 2026 earnings estimated ~2026-08-03, before open (est.) the next real test of the turnaround and the reiterated FY guide. Sits ~7 weeks out, outside the window.
• Summer live-events season (NBA Finals June, concert tours) drives Q2 GMS in real time but is not confirmed in the numbers until the August print.
• Ongoing sell-side revisions are the only near-term mover: the PT cluster has been stepping up (Guggenheim $8.50, JPM $11, MS $10 in June). Further upgrades would extend the re-rating; a downgrade to "underweight" near $11–12 would cap it.

What Would Change Our Mind

• Bullish confirmation: a weekly close and hold above $12.5 (clearing the call-sweep strike and IPO-era overhang), paired with GMS commentary implying the FY guide is conservative that reframes the recovery as reacceleration rather than mean-reversion off the lows.
• Bearish break: a weekly close back below ~$9 forfeits the post-Q1 recovery base and returns control to the busted-IPO downtrend.
• Fundamental invalidation: Q2 (~Aug 3) GMS run-rate tracking below the $9.9–10.1B FY guide, an Adjusted EBITDA cut from the $400–420M range, or net leverage rising back above ~4.5x any of which kills the deleveraging-turnaround narrative the equity is priced on.

Correlation Notes

• Live-events/ticketing complex: trades with Live Nation (LYV) and Vivid Seats (SEAT) on secondary-ticket demand sentiment the 2026-06-08 Knicks/Live Nation headline is the same read flowing through STUB.
• Consumer-discretionary "experiences" spend: sensitive to consumer-health signals; correlates loosely with discretionary names and would de-rate first in a softening-consumer macro.
• Recent-IPO high-beta cohort: thin float and elevated short-term volatility make it swing with risk-on/risk-off rotations independent of company news.
• The "prediction-markets-sports-betting" registry linkage to sportsbook/wagering names (DraftKings, Kalshi-type operators) is a thematic-label artifact only fundamental correlation there is negligible.